Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 3

The study of sirtuins in breast cancer patients before and after radiotherapy

Sayfa
1354–1359
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Finally, the most important thing, in fact, the positive correlation between SIRT1 and SIRT2 both before and after radiotherapy, appears to be clear evidence suggesting more oncogenic roles of sirtuins.Key words: Sirtuin, breast cancer, radiotherapy

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Targeting the new and unique proteins is an important medical strategy for treating breast cancer.
📊
Temel Bulgular & Veri:We aimed to determine the effect of radiotherapy on SIRT1 and SIRT2, which have not been yet been clarified as a tumor suppressor or promoter.Materials and methods: Twenty-two women with nonmetastatic breast cancer enrolled in the study.
💡
Sonuç & Katkı:Finally, the most important thing, in fact, the positive correlation between SIRT1 and SIRT2 both before and after radiotherapy, appears to be clear evidence suggesting more oncogenic roles of sirtuins.Key words: Sirtuin, breast cancer, radiotherapy
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Targeting the new and unique proteins is an important medical strategy for treating breast cancer. It is quite important to find out proteins that have a role in the development of cancer. Sirtuins (SIRT) are well related in different physiological activities and connected with cancer. We aimed to determine the effect of radiotherapy on SIRT1 and SIRT2, which have not been yet been clarified as a tumor suppressor or promoter.Materials and methods: Twenty-two women with nonmetastatic breast cancer enrolled in the study. Blood samples were taken before and after radiotherapy, soluble SIRT1 and SIRT2 levels were determined with ELISA kits.Results: There was no difference in SIRT1 levels before and after radiotherapy (p = 0.548). SIRT2 levels were significantly found to be decreased after radiotherapy (p = 0.042). There was a strong and positive correlation before radiotherapy (p < 0.001), and a moderate and positive correlation after radiotherapy (p = 0.007) between SIRT1 and SIRT2.Conclusion: These results suggest that SIRT2 may provide a new strategy for follow-up of breast cancer treatment. Additionally, by emphasizing the importance of SIRT2 in breast cancer, it opens ways to provide grounds for the development of the next generation of SIRT2-specific radiotracers. Finally, the most important thing, in fact, the positive correlation between SIRT1 and SIRT2 both before and after radiotherapy, appears to be clear evidence suggesting more oncogenic roles of sirtuins.Key words: Sirtuin, breast cancer, radiotherapy

🔖

Bu Makaleye Atıf Yap

KILIÇ, E., YILDIZ, O. G., SARAÇOĞLU, H., HELVACI, N. (2022). The study of sirtuins in breast cancer patients before and after radiotherapy. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1354–1359. https://ajindex.com/articles/609338

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Sparano JA, Fazzari MJ, Childs G. Clinical application of molecular profiling in breast cancer. Future Oncology 2015
  2. 1 (4): 485-496. doi: 10.2217/14796694.1.4.485 2. Boyages J, Baker L. Evolution of radiotherapy techniques in breast conservation treatment. Gland Surgery 2018
  3. 7 (6): 576-595. doi: 10.21037/gs.2018.11.10 3. O’Sullivan CC, Loprinzi CL, Haddad TC. Updates in the evaluation and management of breast cancer. Mayo Clinic Proceedings 2018
  4. 93 (6): 794-807. doi: 10.1016/j. mayocp.2018.03.025 4. Zhou Z, Ma T, Zhu Q, Xu Y, Zha X. Recent advances in inhibitors of sirtuin1/2: an update and perspective. Future Medicinal Chemistry 2018
  5. 10 (8): 907-934. doi: 10.4155/fmc2017-0207 5. Ong ALC, Ramasamy TS. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Research Reviews 2018
  6. doi: 10.1016/j.arr.2018.02.004 6. Zhang W, Liu D, Ren J, Zhou P, Han X. Overexpression of Sirtuin2 prevents high glucose-induced vascular endothelial cell injury by regulating the p53 and NF-κB signaling pathways. Biotechnology Letters 2018
  7. 40 (2): 271-278. doi: 10.1007/ s10529-017-2487-y 7. Karbasforooshan H, Roohbakhsh A, Karimi G. SIRT1 and microRNAs: the role in breast, lung and prostate cancers. Experimental Cell Research 2018
  8. 367 (1): 1-6. doi: 10.1016/j. yexcr.2018.03.023 8. Jiang Y, Liu J, Chen D, Yan L, Zheng W. Sirtuin inhibition: strategies, inhibitors, and therapeutic potential. Trends in Pharmacological Sciences 2017
  9. 38 (5): 459-472. doi: 10.1016/j. tips.2017.01.009 9. Mei Z, Zhang X, Yi J, Huang J, He J et al. Sirtuins in metabolism, DNA repair and cancer. Journal of Experimental & Clinical Cancer Research 2016
  10. 35( 1): 182. doi: 10.1186/s13046-016- 0461-5 10. Kratz EM, Sołkiewicz K, Kubis-Kubiak A, Piwowar A. Sirtuins as important factors in pathological states and the role of their molecular activity modulators. International Journal of Molecular Sciences 2021
  11. 22 (2): 630. doi: 10.3390/ ijms22020630 11. Kleszcz R, Paluszczak J, Baer-Dubowska W. Targeting aberrant cancer metabolism - the role of sirtuins. Pharmacological Reports 2015
  12. 67 (6): 1068-1080. doi: 10.1016/j.pharep.2015.03.021 12. Choi JE, Mostoslavsky R. Sirtuins, metabolism, and DNA repair. Current Opinion in Genetics & Development 2014
  13. doi: 10.1186/s13046-016-0461-5 13. Lin Z, Fang D. The roles of SIRT1 in cancer. Genes and Cancer 2013
  14. 4 (3-4): 97-104. doi: 10.1177/1947601912475079 14. Zhao E, Hou J, Ke X, Abbas MN, Kausar S et al. The r